001     148846
005     20240229123036.0
024 7 _ |a 10.1053/j.gastro.2019.12.020
|2 doi
024 7 _ |a pmid:31884074
|2 pmid
024 7 _ |a 0016-5085
|2 ISSN
024 7 _ |a 1528-0012
|2 ISSN
024 7 _ |a altmetric:73439236
|2 altmetric
037 _ _ |a DKFZ-2020-00038
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Murphy, Neil
|b 0
245 _ _ |a Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses.
260 _ _ |a Philadelphia, Pa. [u.a.]
|c 2020
|b Saunders
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1587469035_30799
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2020 Apr;158(5):1300-1312.e20
520 _ _ |a Human studies examining associations between circulating levels of insulin-like growth factor 1 (IGF1) and insulin-like growth factor binding protein 3 (IGFBP3) and colorectal cancer risk have reported inconsistent results. We conducted complementary serologic and Mendelian randomization (MR) analyses to determine whether alterations in circulating levels of IGF1 or IGFBP3 are associated with colorectal cancer development.Serum levels of IGF1 and other proteins were measured in blood samples collected from 397,380 participants from the UK Biobank, from 2006 through 2010. Incident cancer cases and cancer cases recorded first in death certificates were identified through linkage to national cancer and death registries. Complete follow up was available through March 31, 2016. For the MR analyses, we identified genetic variants associated with circulating levels of IGF1 and IGFBP3. The association of these genetic variants with colorectal cancer was examined with 2-sample MR methods using genome-wide association study consortia data (52,865 cases with colorectal cancer and 46,287 individuals without [controls]) RESULTS: After a median follow-up period of 7.1 years, 2665 cases of colorectal cancer were recorded. In a multivariable-adjusted model, circulating level of IGF1 level associated with colorectal cancer risk (hazard ratio per 1 standard deviation increment of IGF1, 1.11; 95% CI, 1.05-1.17). Similar associations were found by sex, follow-up time, and tumor subsite. In the MR analyses, a 1 standard deviation increment in IGF1 level, predicted based on genetic factors, was associated with a higher risk of colorectal cancer risk (odds ratio, 1.08; 95% CI, 1.03-1.12; P=3.3 x 10-4). Level of IGFBP3, predicted based on genetic factors, was associated with colorectal cancer risk (odds ratio per 1 standard deviation increment, 1.12; 95% CI, 1.06-1.18; P =4.2 x 10-5). Colorectal cancer risk was associated with only 1 variant in IGFBP3 (rs11977526), which also associated with anthropometric traits and circulating level of IGF2.In an analysis of blood samples from almost 400,000 participants in the UK Biobank, we found an association between circulating level of IGF1 and colorectal cancer. Using genetic data from 52,865 cases with colorectal cancer and 46,287 controls, a higher level of IGF1, determined by genetic factors, was associated with colorectal cancer. Further studies are needed to determine how this signaling pathway might contribute to colorectal carcinogenesis.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Carreras-Torres, Robert
|b 1
700 1 _ |a Song, Mingyang
|b 2
700 1 _ |a Chan, Andrew T
|b 3
700 1 _ |a Martin, Richard M
|b 4
700 1 _ |a Papadimitriou, Nikos
|b 5
700 1 _ |a Dimou, Niki
|b 6
700 1 _ |a Tsilidis, Konstantinos K
|b 7
700 1 _ |a Banbury, Barbara
|b 8
700 1 _ |a Bradbury, Kathryn E
|b 9
700 1 _ |a Besevic, Jelena
|b 10
700 1 _ |a Rinaldi, Sabina
|b 11
700 1 _ |a Riboli, Elio
|b 12
700 1 _ |a Cross, Amanda J
|b 13
700 1 _ |a Travis, Ruth C
|b 14
700 1 _ |a Agnoli, Claudia
|b 15
700 1 _ |a Albanes, Demetrius
|b 16
700 1 _ |a Berndt, Sonja I
|b 17
700 1 _ |a Bézieau, Stéphane
|b 18
700 1 _ |a Bishop, D Timothy
|b 19
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 20
|u dkfz
700 1 _ |a Buchanan, Daniel D
|b 21
700 1 _ |a Onland-Moret, N Charlotte
|b 22
700 1 _ |a Burnett-Hartman, Andrea
|b 23
700 1 _ |a Campbell, Peter T
|b 24
700 1 _ |a Casey, Graham
|b 25
700 1 _ |a Castellví-Bel, Sergi
|b 26
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 27
|u dkfz
700 1 _ |a Chirlaque, María-Dolores
|b 28
700 1 _ |a Chapelle, Albert de la
|b 29
700 1 _ |a English, Dallas
|b 30
700 1 _ |a Figueiredo, Jane C
|b 31
700 1 _ |a Gallinger, Steven J
|b 32
700 1 _ |a Giles, Graham G
|b 33
700 1 _ |a Gruber, Stephen B
|b 34
700 1 _ |a Gsur, Andrea
|b 35
700 1 _ |a Hampe, Jochen
|b 36
700 1 _ |a Hampel, Heather
|b 37
700 1 _ |a Harrison, Tabitha A
|b 38
700 1 _ |a Hoffmeister, Michael
|0 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
|b 39
|u dkfz
700 1 _ |a Hsu, Li
|b 40
700 1 _ |a Huang, Wen-Yi
|b 41
700 1 _ |a Huyghe, Jeroen R
|b 42
700 1 _ |a Jenkins, Mark A
|b 43
700 1 _ |a Keku, Temitope O
|b 44
700 1 _ |a Kühn, Tilman
|0 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe
|b 45
|u dkfz
700 1 _ |a Kweon, Sun-Seog
|b 46
700 1 _ |a Le Marchand, Loic
|b 47
700 1 _ |a Li, Christopher I
|b 48
700 1 _ |a Li, Li
|b 49
700 1 _ |a Lindblom, Annika
|b 50
700 1 _ |a Martín, Vicente
|b 51
700 1 _ |a Milne, Roger L
|b 52
700 1 _ |a Moreno, Victor
|b 53
700 1 _ |a Newcomb, Polly A
|b 54
700 1 _ |a Offit, Kenneth
|b 55
700 1 _ |a Ogino, Shuji
|b 56
700 1 _ |a Ose, Jennifer
|b 57
700 1 _ |a Perduca, Vittorio
|b 58
700 1 _ |a Phipps, Amanda I
|b 59
700 1 _ |a Platz, Elizabeth A
|b 60
700 1 _ |a Potter, John D
|b 61
700 1 _ |a Qu, Conghui
|b 62
700 1 _ |a Rennert, Gad
|b 63
700 1 _ |a Sakoda, Lori C
|b 64
700 1 _ |a Schafmayer, Clemens
|b 65
700 1 _ |a Schoen, Robert E
|b 66
700 1 _ |a Slattery, Martha L
|b 67
700 1 _ |a Tangen, Catherine M
|b 68
700 1 _ |a Ulrich, Cornelia M
|b 69
700 1 _ |a van Duijnhoven, Franzel Jb
|b 70
700 1 _ |a Van Guelpen, Bethany
|b 71
700 1 _ |a Visvanathan, Kala
|b 72
700 1 _ |a Vodicka, Pavel
|b 73
700 1 _ |a Vodickova, Ludmila
|b 74
700 1 _ |a Vymetalkova, Veronika
|b 75
700 1 _ |a Wang, Hansong
|b 76
700 1 _ |a White, Emily
|b 77
700 1 _ |a Wolk, Alicja
|b 78
700 1 _ |a Woods, Michael O
|b 79
700 1 _ |a Wu, Anna H
|b 80
700 1 _ |a Zheng, Wei
|b 81
700 1 _ |a Peters, Ulrike
|b 82
700 1 _ |a Gunter, Marc J
|b 83
773 _ _ |a 10.1053/j.gastro.2019.12.020
|g p. S0016508519419513
|0 PERI:(DE-600)1478699-0
|n 5
|p 1300-1312.e20
|t Gastroenterology
|v 158
|y 2020
|x 0016-5085
909 C O |p VDB
|o oai:inrepo02.dkfz.de:148846
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 27
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 39
|6 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 45
|6 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b GASTROENTEROLOGY : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b GASTROENTEROLOGY : 2017
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 1
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 2
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21